Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole: Case report and review of the literature

Samantha E. Jacobs; Deborah Saez-Lacy; Walter Wynkoop; Thomas J. Walsh

doi:10.1093/ofid/ofx040

Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole: Case report and review of the literature

Samantha E. Jacobs
, Deborah Saez-Lacy
, Walter Wynkoop
, Thomas J. Walsh

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.

Original language	English
Article number	ofx040
Journal	Open Forum Infectious Diseases
Volume	4
Issue number	2
DOIs	https://doi.org/10.1093/ofid/ofx040
State	Published - 1 Mar 2017
Externally published	Yes

Keywords

Allergic bronchopulmonary aspergillosis
Antifungal therapy
Isavuconazole

Access to Document

10.1093/ofid/ofx040

Cite this

@article{679fd541ee7f4981981cb57d6a387552,

title = "Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole: Case report and review of the literature",

abstract = "Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.",

keywords = "Allergic bronchopulmonary aspergillosis, Antifungal therapy, Isavuconazole",

author = "Jacobs, \{Samantha E.\} and Deborah Saez-Lacy and Walter Wynkoop and Walsh, \{Thomas J.\}",

note = "Publisher Copyright: {\textcopyright} The Author 2017.",

year = "2017",

month = mar,

day = "1",

doi = "10.1093/ofid/ofx040",

language = "English",

volume = "4",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole

T2 - Case report and review of the literature

AU - Jacobs, Samantha E.

AU - Saez-Lacy, Deborah

AU - Wynkoop, Walter

AU - Walsh, Thomas J.

N1 - Publisher Copyright: © The Author 2017.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.

AB - Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.

KW - Allergic bronchopulmonary aspergillosis

KW - Antifungal therapy

KW - Isavuconazole

UR - https://www.scopus.com/pages/publications/85031894576

U2 - 10.1093/ofid/ofx040

DO - 10.1093/ofid/ofx040

M3 - Article

AN - SCOPUS:85031894576

SN - 2328-8957

VL - 4

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

IS - 2

M1 - ofx040

ER -

Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole: Case report and review of the literature

Abstract

Keywords

Access to Document

Fingerprint

Cite this